Results 91 to 100 of about 18,569 (176)

Depot medroxyprogesterone acetate (DMPA)-associated early-onset osteoporotic fracture

open access: yesEndocrinology, Diabetes & Metabolism Case Reports
Depot medroxyprogesterone acetate (DMPA) is a highly effective injectable contraceptive, but is associated with reduced bone mineral density (BMD) and increased fracture risk in some studies because it inhibits the hypothalamic–pituitary–ovarian axis ...
Yotsapon Thewjitcharoen   +3 more
doaj   +1 more source

The effects of Medroxyprogesterone in corneal melting after Boston Type keratoprosthesis implantation

open access: yes, 2012
The aim of this paper was to assess efficacy of topical medroxyprogesterone (MPG) in melting therapy after Boston type I K Pro implantation. A 73-year-old male patient with full corneal opacity in both eyes underwent a Boston K Pro implantation in the ...
Mazzotta C   +5 more
core   +1 more source

Perbedaan Profil Lipid pada Akseptor Depo Medroksi Progesteron Asetat dengan Implant Levonorgestrel di Wilayah Kerja Puskesmas Air Tawar Padang Tahun 2014

open access: yesJurnal Kesehatan Andalas, 2015
AbstrakDepo Medroksiprogesteron Asetat dan Implant Levonorgestrel merupakan kontrasepsi hormonal progestin sintetik yang memiliki efek samping yaitu peningkatan berat badan dan mempengaruhi metabolisme lipid. Tujuan penelitian ini adalah untuk mengetahui
Rafika Oktova, Desmiwarti ., Arni Amir
doaj  

GnRH Analog Combined with Depot Medroxyprogesterone Acetate in the Management of Endometrial Hyperplasia: A Prospective Randomized Clinical Study

open access: yes, 2016
OBJECTIVE: To compare the effectiveness of combined treatment of depot medroxyprogesterone acetate (MPA) with gonadotropin-releasing hormone (GnRH) analog and depot MPA alone in the management of simple endometrial hyperplasia without atypia among heavy ...
Karabacak, NEŞE   +4 more
core   +1 more source

Pulmonary Lymphangioleiomyomatosis: A Case Report in Postmenopausal Woman Treated with Pleurodesis and Progesterone (Medroxyprogesterone Acetate)

open access: yes, 1996
The main problem in the treatment of pulmonary lymphangioleiomyomatosis, which frequently occurs in the reproductive age, is the control of chylothorax and disease progression.
Mario Lise   +3 more
core   +1 more source

Injectable Contraceptive Use in Women With Intellectual Disability – A Narrative Review and Local Case Series

open access: yesBJPsych Open
Aims: Intellectual Disability is defined as an IQ below 71. People with intellectual disability frequently experience menstrual distress leading to use of hormonal medications such as depot medroxyprogesterone acetate (DMPA).
Marianne Bergman, Alaa Martin
doaj   +1 more source

Medroxyprogesterone Acetate, Nocturnal penile tumescence, laboratory arousal, and sexual acting..

open access: yes, 1990
tag=1 data=Medroxyprogesterone Acetate, Nocturnal penile tumescence, laboratory arousal, and sexual acting... tag=2 data=Cooper, A.J.%Losztyn, S.%Russell, N.C.%Cernovsky, Z. tag=3 data=Archives of Sexual Behavior, Vol 19 No 4 tag=6 data=^d ^m
Cooper, A. J.   +3 more
core  

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis

open access: yes, 1996
Our purpose was to evaluate the efficacy and safety of depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol in the long-term treatment of pelvic pain in women with ...
O. De Giorgi   +5 more
core   +1 more source

The Association Between Medroxyprogesterone Acetate Exposure and Cerebral Meningioma Among a Medicaid Population

open access: yesEpidemiologia
Background/Objectives: Medroxyprogesterone acetate (MPA) is a synthetic contraceptive that can be used orally or as a once-every-three-month injection (i.e., depot MPA [dMPA]).
Lindy M. Reynolds   +2 more
doaj   +1 more source

Administration semestrielle d'acétate de medroxyprogesterone (mpa)

open access: yes, 1979
For more than six years the authors have studied the acceptability and the effectiveness of Medroxyprogesterone Acetate (450 mg) as a long-acting contraceptive (six months).
Molitor-Peffer, M.P.   +2 more
core  

Home - About - Disclaimer - Privacy